title: Myomas and assisted reproductive technologies: when and how to act?
abstract: The effect of myomas on reproductive outcome has been the subject of many studies; however, a definitive answer is still missing. Therefore, the authors have tried to outline some guidelines for the management of women who have uterine myomas and desire to conceive. The location and size of the myomas are the two parameters that influence the success of a future pregnancy. Subserosal myomas seem to have little, if any,effect on reproductive outcome, especially if they are up to 5 to 7 cm in diameter. Intramural myomas that do not encroach upon the endometrium also can be considered to be relatively harmless to reproduction, if they are smaller than 4 to 5 cm in diameter. This is the ambiguous gray zone of the subject, and where research should be focused before a consensus can be established. Myomas that compress the uterine cavity with an intramural portion (submucous myoma type II) and submucous myomas significantly reduce pregnancy rates, and should be removed before assisted reproductive techniques are used. Hysteroscopic myomectomy is the gold standard for the treatment of submucous myomas. For other myomas, abdominal myomectomy, or laparoscopic myomectomy--when the experience of the surgeon and the facilities are sufficient--are the best alternatives. In most of the literature, the pregnancy rates were increased and the miscarriage rates were decreased after surgery with these two techniques. Other alternative treatment modalities, such as CUV, laparoscopic myolysis, or MRI-guided focused ultrasound, are to be monitored and evaluated thoroughly before they are applied as routine procedures.
authors.affiliation: Infertility and IVF Unit, Department of Obstetrics and Gynecology, Anadolu Health Center, Affiliated with Johns Hopkins Medicine, Anadolu Saglik Merkezi, Anadolu Cad. No: 1, Cayirova, Gebze, 41400 Kocaeli, Turkey. aytug.kolankaya@anadolusaglik.org
authors.forename: Aytug
authors.initials: A
authors.lastname: Kolankaya
authors.forename: Aydin
authors.initials: A
authors.lastname: Arici
mesh_terms: D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000150:complications* / Q000628:therapy; D007889:Leiomyoma / Q000150:complications*; D011247:Pregnancy; D011256:Pregnancy Outcome; D027724:Reproductive Techniques, Assisted; D016896:Treatment Outcome; D014594:Uterine Neoplasms / Q000150:complications*